Taiwan FDA registration 237090ec4422d2a934635232a3f7d7e2
"Kabi" Ambi-Implantable Injection System
TW: “卡比”安比適植入型注射系統
Taiwan·Risk Class 2·Fresenius Kabi AG;; CLINICO MEDICAL SP. Z.O.O. BŁONIE NEAR WROCŁAW·Registered Oct 18, 2017 – Oct 18, 2027ActiveRegistration details
- Analysis ID
- 237090ec4422d2a934635232a3f7d7e2
- Customs Code
- DHA05603035100
Company information
- Manufacturer Country
- Germany;;Poland
- Authorized Representative
- FRESENIUS KABI TAIWAN LIMITED
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5965 Subcutaneous implantable intravascular injection port and guide
- Import Information
- import
Dates and status
- Registration Date
- Oct 18, 2017
- Expiry Date
- Oct 18, 2027
About this record
Access comprehensive regulatory information for "Kabi" Ambi-Implantable Injection System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 237090ec4422d2a934635232a3f7d7e2 and manufactured by Fresenius Kabi AG;; CLINICO MEDICAL SP. Z.O.O. BŁONIE NEAR WROCŁAW. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices